Fulvestrant CAS 129453-61-8

Product Description:

Khoom npe: Fulvestrant CAS NO: 129453-61-8

Synonyms:

(7a,17b)-7-[9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17-diol;

estra-1,3,5(10)-triene-3,17-diol,7-(9-((4,4,5,5,5-pentafluoropentyl)sulfinyl);

Fulvtrant;

Tshuaj& Lub cev muaj zog:

Qhov tsos: Dawb hmoov

Kev Ntsuas: ≥99.0%

Qhov ceev: 1.201 g / cm3

Boiling Point: 674.8 ℃ ntawm 760 mmHg

Flash Point: 361.9 ℃

Refractive Index: 1.521

Cia txias: 2-8 ℃

Vapor Siab: 3.95E-19mmHg ntawm 25 ℃

Cov ntaub ntawv kev nyab xeeb:

RTECS: KG7623000

HS Code: 2930909090

WGK Germany: 3

Fulvestrant (lub npe lag luam Faslodex, los ntawm AstraZeneca) yog cov tshuaj kho mob ntawm cov tshuaj hormone receptor-zoo metastatic mis mob qog noj ntshav hauv cov poj niam postmenopausal nrog cov kab mob tshwm sim tom qab kev kho tshuaj estrogen. Nws yog ua tiav cov tshuaj estrogen receptor antagonist uas tsis muaj cov teebmeem agonist, uas ntxiv rau, ua kom cov proteasomal degradation ntawm cov tshuaj estrogen receptor. Cov tshuaj muaj qhov tsis zoo ntawm qhov ncauj bioavailability, thiab yog siv txhua hli ntawm kev txhaj tshuaj intramuscular.

Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov koj xav tiv tauj peb!

Cov khoom raws li patent muaj rau R& D lub hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm kawg tsuas yog nrog tus neeg yuav khoom.

Cim npe nrov: Fulvestrant CAS 129453-61-8, tuam ntxhab, lwm tus muag khoom, Hoobkas, yuav, hauv Tshuag

• Tug: Estr-9-en-3-one, 11-[4-(dimethylamino)phenyl]-5,17-dihydroxy-17-(1-propynyl)-, Cyclic 1,2-ethanediyl Acetal, (5a,11b,17b CAS Nr .: 84371-64-2
• Tom ntej: Trilostane CAS 13647-35-3